EWP, which targets non- branded drugmakers in developing countries, said that installation of the first production line at the, as yet unnamed, firm's production facility in Sunyani is due to be fully operational sometime next month.
EWP president Brandon Keks said: “We expect to have the initial revenues from the first line of production within the second quarter of 2010,” adding that his group may invest further in due course.
The group expects that, when the second production line is installed, operations will generate revenue of more than $20m (€14.7m) a year.